The unlisted shares of Senores Pharmaceuticals Ltd are currently trading at Rs 631 per share in the gray market, which is 61.38% higher than the IPO issue price of Rs 391. This marks the outstanding listing on December 30.
Senores Pharmaceuticals IPO.
Senores Pharmaceuticals IPO Allotment Status: Allotment of Senores Pharmaceuticals IPO has been finalized. The initial public offering of Senores Pharmaceuticals Ltd closed on Tuesday and received an aggregate subscription of 97.86 times. The Senores Pharmaceuticals IPO listing will take place on Monday, December 30. The latest GMP currently stands at 61.38 percent, indicating a strong listing.
Senores Pharmaceuticals Ltd’s initial public offering, which was opened between December 20 and December 24, was oversubscribed 97.86 times. The retail category received an overall subscription of 93.16 times, the NII (non-institutional investors) segment received a subscription of 100.35 times. Its QIB (Qualified Institutional Buyer) category is oversubscribed 97.84 times.
The price band of the IPO was fixed at Rs 372 to Rs 391 per piece.
Shares of Senores Pharmaceuticals Ltd are scheduled to be listed on both BSE and NSE on Monday, December 30.
The allotment of the IPO has been finalized on Thursday evening. Investors who have been allotted IPO received a bank debit message. Investors can check the IPO allotment status on the BSE and NSE websites as well as on the registrar link-in-time portal.
Senores Pharmaceuticals IPO GMP Today
According to market observers, the unlisted shares of Senores Pharmaceuticals Ltd are currently trading at Rs 631 per share in the gray market, which is Rs 240 or 61.38% higher than the IPO issue price of Rs 391. .
GMP is based on market sentiment and changes. The ‘grey market premium’ indicates the willingness of investors to pay more than the issue price.
Senores Pharmaceuticals IPO: How to Check Allotment Status Online?
IPO allotment status can be checked online by following these steps:
1) Visit BSE official website via URL —https://www.bseindia.com/investors/appli_check.aspx.
2) Under ‘Issue Type’, select ‘Equity’.
3) Under ‘Issue Name’, select ‘Senores Pharmaceuticals Ltd’ in the Dropbox.
4) Enter your Application Number, or Permanent Account Number (PAN).
5) Then, click on ‘I am not a robot’ to confirm yourself and press ‘Search’ option.
The status of your share request will be displayed on your screen.
You can also visit the portal of Direct Link in Time Limited. https://www.linkintime.co.in/Initial_Offer/public-issues.html And Check Senores Pharmaceuticals IPO Allotment Status
Senores Pharmaceuticals IPO: More details
The Ahmedabad-based company’s IPO is a combination of a fresh issue of shares worth Rs 500 crore and an offer for sale (OFS) of 2.1 lakh shares worth up to Rs 82.11 crore, priced by promoters and other selling shareholders, above Rs. – End of price band.
Senores Pharmaceuticals Ltd has raised around Rs 261 crore from anchor investors.
Proceeds from the fresh issue will be used to set up a manufacturing facility for sterile injectables at its Atlanta facility. Meeting the working capital requirements of the Company and its subsidiaries, supporting inorganic growth through acquisitions and other strategic initiatives and debt repayments. In addition, a portion will be used for general corporate purposes.
Senores Pharmaceuticals specializes in the identification, development, and manufacturing of a wide array of specialty, nonpreserved, and complex pharmaceutical products, positioning itself as a preferred partner for select customers.
The company has several products in major therapeutic segments, including antibiotics, antibacterials, antifungals, and bloodlines.
As of March 2024, the company had three R&D facilities in India and the US and is in the process of consolidating R&D facilities at a proposed dedicated facility in Ahmedabad.
Equirus Capital, Ambit, and Nuvama Wealth Management are the book-running lead managers to the issue.
Equity shares are proposed to be listed on BSE and NSE.